Planned intervention: On Wednesday June 26th 05:30 UTC Zenodo will be unavailable for 10-20 minutes to perform a storage cluster upgrade.
Published August 5, 2021 | Version v1
Figure Open

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance - Unpublished data

  • 1. Experimental Pharmacology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy

Description

Antitumor effects of valproic acid (VPA) in combination with Cisplatin/Cetuximab doublet in head and neck squamous cell carcinoma (HNSCC) models. We reported unpublished data of the effects of this combination on cell cycle and 3D cell cultures

Files

Iannelli et al 3D colture.pdf

Files (1.1 MB)

Name Size Download all
md5:b78031bbe5dbcb9e86fa7b35833bb93d
516.8 kB Preview Download
md5:fac43f8b84350eee52845969729feac8
565.6 kB Preview Download

Additional details

Related works

Is supplement to
Journal article: 10.3389/fcell.2020.00732 (DOI)